Advertisement
Viekira Pak Coupon - Viekira Pak 112 tablets of 12.5mg/75mg/50mg and 250mg carton
Viekira Pak
Specialty Drug

Dasabuvir / Ombitasvir / Paritaprevir And Ritonavir

DASABUVIR; OMBITASVIR; PARITAPREVIR; RITONAVIR (da sa' bue vir; om bit' as vir; par'' i ta' pre vir; ri toe' na veer) is a combination of four medicines. It is used to treat hepatitis C. It will not work for colds, flu, or other viral infections. Compare hepatitis C protease / nucleotide polymerase / NS5A inhibitor combinations.
Viekira Pak Coupon - Viekira Pak 112 tablets of 12.5mg/75mg/50mg and 250mg carton
Advertisement

Viekira Pak Latest News

Get the latest updates on this drug from the GoodRx medical team

FDA Safety Alert: Direct-Acting Antivirals for Hepatitis C

The GoodRx Pharmacist - November 12, 2016

The FDA has issued a drug safety alert for direct-acting antivirals used to treat Hepatitis C. They warn that using direct-acting antivirals such as Sovaldi, Harvoni, or Zepatier can cause a reactivation of Hepatitis B in patients who have been previously infected with the virus.

The FDA gained knowledge about the reactivation of hepatitis B occurring from direct-acting antivirals through reported incidents and published literature. See More

2015 In Review: The Good(Rx) and Bad

Elizabeth Davis - December 29, 2015

2015 was another tough year for American’s health care budgets. Insurance premiums increased, coverage was dropped for a number of important drugs, and overall we’re spending more for our health care.

Don’t break out the antidepressants yet—it’s not all bad news. A number of important drugs went generic, which will generally mean huge savings and lower costs. Plus, a large number of drugs actually decreased in price. See More

Why Are So Many Drug Prices Increasing?

The GoodRx Pharmacist - September 30, 2015

If you’ve been following the news, huge price increases on necessary drugs like Daraprim and cycloserine may seem unusual—they both dropped in price again once people noticed and complained, right?

The unfortunate reality as that price increases happen in the pharmaceutical industry day-in and day-out. While the majority aren’t quite as dramatic as the Daraprim price hike, they happen more often than you might think. See More

New GoodRx Top 10 Drug Guide

Elizabeth Davis - June 05, 2015

Our new top 10 lists are in for the most-dispensed and most expensive prescriptions in the US—take a look at these interesting updates.

Which prescriptions have been filled the most in 2015 so far?

Based on a sample of claims reported by pharmacies across the country, thyroid meds like Synthroid and levothyroxine near the top of the list, while standard heart and diabetes prescriptions lisinopril (Zestril, Prinivil), atorvastatin (Lipitor), and metformin (Glucophage) are still very frequently prescribed—no surprises there. See More

GoodRx Top 10 Drug Guide

Elizabeth Davis - February 06, 2015

We’ve updated our lists of the Top 10 most-dispensed and most expensive prescriptions in the US, with some interesting changes from the end of 2014.

Curious about the most popular prescriptions?

Based on a sample of claims reported by pharmacies across the country, some common antibiotics, like amoxicillin (Amoxil) and azithromycin (Zithromax) top the list, along with heart meds like atorvastatin (Lipitor) and lisinopril (Zestril, Prinivil). See More

Express Scripts vs Caremark: The Battle for Hepatitis C Coverage

The GoodRx Pharmacist - January 14, 2015

In the past year, the realm of hepatitis C treatment has been flourishing. Several new medications have received FDA approval and have changed the way we treat this often silent disease.

With the introduction of new first line treatments, slowly but surely, we will begin to see the discontinuation of many older hepatitis C treatments. Incivek was pulled by its manufacturer, Vertex Pharmaceuticals, back in October. See More

Viekira Pak: New Hepatitis C Med Now Available

The GoodRx Pharmacist - January 05, 2015

Viekira Pak was approved by the FDA on December 19, 2015 as the newest treatment for chronic hepatitis C (genotype 1), and is already available to patients. Genotype 1 is the most common in the US, affecting around 75% of Americans with the virus.

Were there any special circumstances for the approval of Viekira Pak?

Yes. Viekira Pak was designated a breakthrough therapy. That means the approval process could be completed faster than usual. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.